Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Confidence In Factor XIa Inhibition Wavers After Bristol/Janssen And Bayer Data
High Expectations For Next Big Oral Anticoagulant Drug Class
Aug 29 2022
•
By
Mandy Jackson
Phase II trials left several unanswered questions for milvexian and asundexian • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Clinical Trials
More from R&D